Project Grant K99CA296217
Award Date 8/1/25
Completion Date 7/31/27
Dollars Obligated $108K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Virginia, USA
Similar Awards
- This $433,185 federal Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health federal grant program (CFDA 93.113) will support research by the Harvard T.H. Chan School of Public Health to examine the associations between ambient particle radioactivity (PR) exposure and lung cancer survival. The study aims to assess the effects of pre- and post-diagnosis exposures to PR on overall and progression-free survival among lung cancer...
- The National Cancer Institute awarded a $140,130 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for the project "Elucidating Thiol Reductive Stress in Lung Cancer Growth and Metastasis." The award period is from March 1, 2025, to February 28, 2027. This project grant supports research to investigate the impact of reductive stress, a specific vulnerability in a subset...
- This $376,314 federal Project Grant was awarded by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to Drexel University on August 8, 2025. The objective of this study is to examine cause-specific cancer mortality in relation to levels of unregulated contaminants in public water systems. The research will be conducted through linkage of individual survey records from the Mortality Disparities in American Communities (MDAC) cohort with measurement of...
- This Project Grant award from the National Institute of Environmental Health Sciences (NIEHS), under the Environmental Health (CFDA 93.113) federal grant program, will support research by the University of California, Davis (UC Davis) to investigate the role of the aryl hydrocarbon receptor (AhR) in mediating the tumor-promoting effects of traffic-related air pollution (TRAP) exposure in breast cancer. The $495,598 award, effective November 22, 2024 through October 31, 2029, will enable UC Davis...
- This $137,322 Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) supports research by Trustees of Boston University to develop disulfated polyamidosaccharide nanoparticles as a P-selectin targeting chemotherapeutic delivery system. The goal is to create a more targeted and effective treatment for breast and lung cancers, which disproportionately affect women, including many non-smokers. The research will leverage the upregulation of P-selectin on...
- The National Cancer Institute (NCI) awarded a $432,304 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to The Trustees of Columbia University in the City of New York, Health Sciences Division. The grant, awarded on January 3, 2025, supports a 5-year research project focused on "Enhanced Cancer Risk Predictions in Underrepresented Populations through Robust Multi-Source Data Integration." The project aims to develop novel data integration methods to...
- The federal Project Grant award of $397,772 was provided by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research program) to Harvard T.H. Chan School of Public Health. The grant will fund the development of computational methods for profiling the cancer virome and analyzing microbial strain genetics from shotgun metagenomes and metatranscriptomes. This research aims to address key knowledge gaps in understanding the role of viruses and microbial strain variations...
- The University of Colorado-Denver was awarded a $1,344,022 Project Grant by the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) to investigate the role of respiratory viral infections and inflammation in promoting metastatic outgrowth of breast cancer in the lung. The 5-year grant, with an award date of March 1, 2025, aims to determine the mechanisms by which acute respiratory viral infections induce the awakening of dormant disseminated cancer cells, leading to metastatic...
- This Project Grant award of $162,305 from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) supports research to model and characterize the early cellular and molecular changes that occur upon activation of the anaplastic lymphoma kinase (ALK) in lung cancer. The project, led by Dr. Peggy Hsu at the University of Michigan, aims to develop a single cell atlas of ALK+ lung cancer, examine the role of the transcription factor NRF2 in ALK+ lung cancer initiation, and provide a...
- This federal Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $119,172 to The Leland Stanford Junior University (Stanford University) from August 1, 2025 to July 31, 2027. The project aims to harness multi-modal and multi-omics data integration to decipher therapeutic response in non-small cell lung cancer. The research seeks to characterize the spatial interactions between tumor cells and their microenvironment using high-dimensional,...